US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
US4452773A
(en)
|
1982-04-05 |
1984-06-05 |
Canadian Patents And Development Limited |
Magnetic iron-dextran microspheres
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
GB8311018D0
(en)
|
1983-04-22 |
1983-05-25 |
Amersham Int Plc |
Detecting mutations in dna
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
US4795698A
(en)
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US5204244A
(en)
|
1987-10-27 |
1993-04-20 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
ES2067018T3
(es)
|
1988-12-28 |
1995-03-16 |
Stefan Miltenyi |
Procedimiento y materiales para la separacion en alto gradiente magnetico de materiales biologicos.
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5130538A
(en)
|
1989-05-19 |
1992-07-14 |
John B. Fenn |
Method of producing multiply charged ions and for determining molecular weights of molecules by use of the multiply charged ions of molecules
|
US5581080A
(en)
|
1989-05-19 |
1996-12-03 |
Fenn; John B. |
Method for determining molecular weight using multiply charged ions
|
WO1990014148A1
(en)
|
1989-05-19 |
1990-11-29 |
Fenn John B |
Multiply charged ions and a method for determining the molecular weight of large molecules
|
FR2650840B1
(fr)
|
1989-08-11 |
1991-11-29 |
Bertin & Cie |
Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
|
AU625013B2
(en)
|
1989-11-03 |
1992-06-25 |
Vanderbilt University |
Method of in vivo delivery of functioning foreign genes
|
AU7492291A
(en)
|
1990-02-26 |
1991-09-18 |
Board Of Trustees Of The Leland Stanford Junior University |
Identification and expression of insect steroid receptor dna sequences
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
US5204253A
(en)
|
1990-05-29 |
1993-04-20 |
E. I. Du Pont De Nemours And Company |
Method and apparatus for introducing biological substances into living cells
|
US5200084A
(en)
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
US6004744A
(en)
|
1991-03-05 |
1999-12-21 |
Molecular Tool, Inc. |
Method for determining nucleotide identity through extension of immobilized primer
|
EP0646178A1
(en)
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
expression cassette with regularoty regions functional in the mammmlian host
|
US5608217A
(en)
|
1994-03-10 |
1997-03-04 |
Bruker-Franzen Analytik Gmbh |
Electrospraying method for mass spectrometric analysis
|
DE4444229C2
(de)
|
1994-03-10 |
1996-07-25 |
Bruker Franzen Analytik Gmbh |
Verfahren und Vorrichtungen zur Elektrosprüh-Ionisierung für speichernde Massenspektometer
|
US5534615A
(en)
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
US8956621B2
(en)
|
1994-11-08 |
2015-02-17 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical dysplasia
|
US8114414B2
(en)
|
1994-11-08 |
2012-02-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical cancer
|
US6071890A
(en)
|
1994-12-09 |
2000-06-06 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
WO1999019484A1
(en)
|
1997-10-10 |
1999-04-22 |
Basf Aktiengesellschaft |
T cell receptor-associated molecules (trams) and methods of use therefor
|
DE19937828C1
(de)
|
1999-08-11 |
2000-10-05 |
Smb Schwede Maschinenbau Gmbh |
Schweißkopf für eine Bandumreifungsmaschine
|
AU7508100A
(en)
|
1999-10-04 |
2001-05-10 |
Jens Andersen |
Human seizure related proteins
|
JP5031967B2
(ja)
|
2000-03-22 |
2012-09-26 |
イントレキソン コーポレーション |
新規エクジソン受容体ベースの誘導性遺伝子発現系
|
US9012141B2
(en)
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
CA2413211A1
(en)
*
|
2000-04-04 |
2001-10-11 |
University Of Rochester |
A gene differentially expressed in breast and bladder cancer and encoded polypeptides
|
WO2001094935A2
(en)
|
2000-06-09 |
2001-12-13 |
Mds Proteomics, Inc. |
Labeling of proteomic samples during proteolysis for quantitation and sample multiplexing
|
GB0018901D0
(en)
*
|
2000-08-03 |
2000-09-20 |
Biovation Ltd |
Peptides presented by cells
|
US20020192708A1
(en)
|
2000-10-25 |
2002-12-19 |
Hanno Steen |
Detection of modified amino acids by mass spectrometry
|
ES2390425T3
(es)
|
2000-12-22 |
2012-11-12 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Uso de moléculas de orientación repulsivas (RGM) y sus moduladores
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
WO2002080649A2
(en)
|
2001-04-09 |
2002-10-17 |
Mds Proteomics, Inc. |
Methods and systems for searching genomic databases
|
US7731648B2
(en)
|
2001-07-25 |
2010-06-08 |
Aduro Biotech |
Magnetic nanoscale particle compositions, and therapeutic methods related thereto
|
AU2002343601A1
(en)
|
2001-10-31 |
2003-05-12 |
Mds Proteomics, Inc. |
Proteins involved in regulation of adipocytes and uses related thereto
|
DE10211088A1
(de)
|
2002-03-13 |
2003-09-25 |
Ugur Sahin |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
WO2003087162A2
(en)
|
2002-04-18 |
2003-10-23 |
Mtm Laboratories Ag |
Neopeptides and methods useful for detection and treatment of cancer
|
US20050221350A1
(en)
|
2002-05-29 |
2005-10-06 |
Toni Weinschenk |
Method for identifying immunoreactive peptides
|
US7176022B2
(en)
|
2002-12-20 |
2007-02-13 |
Cell Genesys, Inc. |
Directly injectable formulations which provide enhanced cryoprotection of cell products
|
JP4545151B2
(ja)
|
2003-02-06 |
2010-09-15 |
シーラス コーポレイション |
非食細胞中への侵入について減弱化されているリステリア、そのリステリアを含むワクチン、およびそれらの使用法
|
AU2004224425B2
(en)
|
2003-02-06 |
2010-06-24 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
ES2395126T3
(es)
|
2003-02-28 |
2013-02-08 |
Agenus Inc. |
Uso de lectinas para promover la oligomerización de glicoproteínas y de moléculas antigénicas
|
US20040197312A1
(en)
|
2003-04-02 |
2004-10-07 |
Marina Moskalenko |
Cytokine-expressing cellular vaccine combinations
|
DE10341812A1
(de)
|
2003-09-10 |
2005-04-07 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
DE10344799A1
(de)
|
2003-09-26 |
2005-04-14 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
EP1708741B1
(en)
|
2003-12-24 |
2016-03-30 |
Aduro Biotech |
Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
|
DE102004023187A1
(de)
|
2004-05-11 |
2005-12-01 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
US20070265818A1
(en)
|
2004-08-24 |
2007-11-15 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational methods and systems for heightening cell-mediated immune response
|
US20060095241A1
(en)
|
2004-10-29 |
2006-05-04 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US7220549B2
(en)
|
2004-12-30 |
2007-05-22 |
Helicos Biosciences Corporation |
Stabilizing a nucleic acid for nucleic acid sequencing
|
US7283337B2
(en)
|
2005-03-04 |
2007-10-16 |
Headway Technologies, Inc. |
Abutted exchange bias design for sensor stabilization
|
DE102005013846A1
(de)
|
2005-03-24 |
2006-10-05 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
PT1760088E
(pt)
|
2005-09-05 |
2008-05-14 |
Immatics Biotechnologies Gmbh |
Péptidos associados a tumores que se ligam promiscuamente a moléculas de antigénio leucocitário humano (hla) de classe ii
|
EP1762575A1
(en)
|
2005-09-12 |
2007-03-14 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated antigens for diagnosis and therapy
|
CA2651796A1
(en)
|
2006-02-27 |
2007-09-07 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Identification and use of novopeptides for the treatment of cancer
|
US9732131B2
(en)
|
2006-02-27 |
2017-08-15 |
Calviri, Inc. |
Identification and use of novopeptides for the treatment of cancer
|
US7935804B2
(en)
|
2006-03-01 |
2011-05-03 |
Aduro Biotech |
Engineered Listeria and methods of use thereof
|
EP2860253B1
(en)
|
2006-03-01 |
2018-08-01 |
Aduro Biotech, Inc. |
Engineered listeria and methods of use thereof
|
US7919079B2
(en)
|
2006-03-31 |
2011-04-05 |
Biosante Pharmaceuticals, Inc. |
Cancer immunotherapy compositions and methods of use
|
US8768629B2
(en)
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
DE102006032362A1
(de)
|
2006-07-13 |
2008-01-17 |
Khd Humboldt Wedag Gmbh |
Rollenpresse insbesondere zur Gutbettzerkleinerung
|
US8926993B2
(en)
|
2006-07-17 |
2015-01-06 |
Aduro Biotech |
Methods and compositions using Listeria for enhancing immunogenicity by prime boost
|
US8121797B2
(en)
|
2007-01-12 |
2012-02-21 |
Microsoft Corporation |
T-cell epitope prediction
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
US20090004213A1
(en)
|
2007-03-26 |
2009-01-01 |
Immatics Biotechnologies Gmbh |
Combination therapy using active immunotherapy
|
DK2567707T3
(en)
|
2007-07-27 |
2017-07-31 |
Immatics Biotechnologies Gmbh |
Composition of tumour-associated peptides and related anti-cancer vaccine
|
KR101351195B1
(ko)
|
2007-07-27 |
2014-01-14 |
이매틱스 바이오테크놀로지스 게엠베하 |
면역 치료를 위한 새로운 면역원성 에피톱
|
NZ582824A
(en)
|
2007-07-27 |
2012-07-27 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against neuronal and brain tumors
|
WO2009034190A2
(en)
|
2007-09-14 |
2009-03-19 |
Genimmune N.V. |
Affinity tag
|
EP2060583A1
(en)
|
2007-10-23 |
2009-05-20 |
Ganymed Pharmaceuticals AG |
Identification of tumor-associated markers for diagnosis and therapy
|
ES2374863T3
(es)
|
2007-12-07 |
2012-02-22 |
Miltenyi Biotec Gmbh |
Centrífuga para separar una muestra en por lo menos dos componentes.
|
EP2091046A1
(en)
|
2008-02-15 |
2009-08-19 |
Thomson Licensing |
Presentation system and method for controlling the same
|
PL2113253T3
(pl)
|
2008-04-30 |
2010-09-30 |
Immatics Biotechnologies Gmbh |
Nowa postać leku - preparat zawierający peptydy nowotworowe wiążące się z antygenami ludzkich leukocytów klasy I i II, zastosowany w szczepionce
|
US20120164718A1
(en)
|
2008-05-06 |
2012-06-28 |
Innovative Micro Technology |
Removable/disposable apparatus for MEMS particle sorting device
|
DK2119726T5
(en)
|
2008-05-14 |
2018-03-26 |
Immatics Biotechnologies Gmbh |
Novel and powerful MHC class II peptides derived from survivin and neurocan
|
US20150366955A9
(en)
|
2009-11-11 |
2015-12-24 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
DK2853269T3
(da)
|
2008-05-19 |
2019-08-05 |
Advaxis Inc |
Dobbelt indgivelsessystem til heterologe antigener, der omfatter en rekombinant Listeria-stamme svækket ved mutation af dal/dat og deletion af ActA, der omfatter et nukleinsyremolekyle, der koder for et listeriolysin O-prostataspecifikt antigenfusionsprotein
|
US20140234370A1
(en)
|
2009-11-11 |
2014-08-21 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
AU2009249273A1
(en)
|
2008-05-19 |
2009-11-26 |
Aduro Biotech |
Compositions comprising PrfA*mutant listeria and methods of use thereof
|
US8840881B2
(en)
|
2008-08-28 |
2014-09-23 |
Aduro Gvax Inc. |
Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
|
EP3216874A1
(en)
|
2008-09-05 |
2017-09-13 |
TOMA Biosciences, Inc. |
Methods for stratifying and annotating cancer drug treatment options
|
SI2172211T1
(sl)
|
2008-10-01 |
2015-03-31 |
Immatics Biotechnologies Gmbh |
Sestavek s tumorjem povezanih peptidov in zadevnih cepiv proti raku za zdravljenje glioblastoma (GBM) in drugih vrst raka
|
DK2865387T3
(da)
|
2008-11-21 |
2019-08-26 |
Univ Copenhagen |
Forberedelse af en immunreaktion
|
ES2928709T3
(es)
|
2009-03-02 |
2022-11-22 |
Aduro Biotech Holdings Europe B V |
Anticuerpos frente a un ligando inductor de proliferación (APRIL)
|
EP3138854B1
(en)
|
2009-03-10 |
2022-01-26 |
Baylor Research Institute |
Antibodies against cd40
|
US20120077696A1
(en)
|
2009-03-15 |
2012-03-29 |
Technion Research And Development Foundation Ltd. |
Soluble hla complexes for use in disease diagnosis
|
AU2010232490B2
(en)
|
2009-04-03 |
2016-08-11 |
Agenus Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
EP2309262A1
(en)
|
2009-10-06 |
2011-04-13 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for quantifying biomolecules
|
EP2498808A4
(en)
|
2009-11-11 |
2014-01-08 |
Advaxis |
COMPOSITIONS AND METHOD FOR PREVENTING FLUID MUTATIONS IN THE TREATMENT OF TUMORS WITH HER2 / NEW OVEREXPRESSION
|
US20110223187A1
(en)
|
2010-02-15 |
2011-09-15 |
Vafa Shahabi |
Live listeria-based vaccines for central nervous system therapy
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
GB201004575D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
|
ES2564841T3
(es)
|
2010-05-14 |
2016-03-29 |
The General Hospital Corporation |
Composiciones y métodos para identificar neoantígenos específicos de un tumor
|
ES2613630T3
(es)
|
2010-05-23 |
2017-05-25 |
Aduro Biotech, Inc. |
Métodos y composiciones que utilizan Listeria para un tratamiento auxiliar del cáncer
|
WO2011149909A2
(en)
|
2010-05-24 |
2011-12-01 |
Hunt Donald F |
Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
|
JP6023706B2
(ja)
|
2010-07-09 |
2016-11-09 |
アデュロ・バイオテック・ホールディングス・ヨーロッパ・ベスローテン・フエンノートシャップAduro Biotech Holdings, Europe B.V. |
Cd27に対するアゴニスト抗体
|
WO2012035066A1
(en)
|
2010-09-14 |
2012-03-22 |
Max-Planck-Gesellschaft Zur Förderung Der Wissenschften E.V. |
Hot1 and uses thereof
|
GB201015765D0
(en)
|
2010-09-21 |
2010-10-27 |
Immatics Biotechnologies Gmbh |
Use of myeloid cell biomarkers for the diagnosis of cancer
|
US9226958B2
(en)
|
2010-10-01 |
2016-01-05 |
University Of Georgia Research Foundation, Inc. |
Use of Listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
|
US9200057B2
(en)
|
2010-11-17 |
2015-12-01 |
Providence Health & Services-Oregon |
Methods and compositions for inducing an immune response to EGFRvIII
|
GB201021289D0
(en)
|
2010-12-15 |
2011-01-26 |
Immatics Biotechnologies Gmbh |
Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
|
BR112013016708B1
(pt)
|
2010-12-30 |
2021-08-17 |
Foundation Medicine, Inc |
Otimização de análise multigene de amostras de tumor
|
CN103687611A
(zh)
|
2011-03-11 |
2014-03-26 |
阿德瓦希斯公司 |
基于李斯特菌属的佐剂
|
EP2508537A1
(en)
|
2011-04-04 |
2012-10-10 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Quantitative standard for mass spectrometry of proteins
|
RS62497B1
(sr)
|
2011-05-24 |
2021-11-30 |
BioNTech SE |
Individualizovane vakcine protiv kancera
|
JP2015511602A
(ja)
|
2012-03-12 |
2015-04-20 |
アドバクシス, インコーポレイテッド |
リステリアワクチン処理後のサプレッサー細胞機能抑制
|
WO2013158611A1
(en)
|
2012-04-16 |
2013-10-24 |
Agenus Inc. |
Methods and compositions for the treatment of glioblastomas
|
MX364370B
(es)
|
2012-07-12 |
2019-04-24 |
Persimmune Inc |
Vacunas contra el cancer personalizadas y terapias de celulas inmunes adoptivas.
|
CN107817348A
(zh)
|
2012-09-05 |
2018-03-20 |
亚利桑那州评议委员会,亚利桑那州法人团体,代理和代表亚利桑那州立大学 |
发现治疗靶标的方法
|
RU2678127C2
(ru)
|
2012-11-13 |
2019-01-23 |
Бионтех Аг |
Агенты для лечения экспрессирующих клаудин раковых заболеваний
|
EP2925348B1
(en)
|
2012-11-28 |
2019-03-06 |
BioNTech RNA Pharmaceuticals GmbH |
Individualized vaccines for cancer
|
SG10201704611WA
(en)
|
2012-12-13 |
2017-07-28 |
Aduro Biotech Inc |
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
|
ES2939121T3
(es)
|
2012-12-19 |
2023-04-19 |
Max Planck Gesellschaft |
Recipiente de reacción para preparación de muestras
|
JP2016503655A
(ja)
|
2012-12-27 |
2016-02-08 |
アデュロ バイオテック,インコーポレイテッド |
リステリアの抗原配列の発現を容易にするシグナルペプチド融合パートナー、ならびにその調製方法およびその使用
|
CN110423282B
(zh)
|
2013-02-15 |
2023-09-08 |
加利福尼亚大学董事会 |
嵌合抗原受体及其使用方法
|
CA2908434C
(en)
|
2013-04-07 |
2021-12-28 |
The Broad Institute, Inc. |
Compositions and methods for personalized neoplasia vaccines
|
WO2014180490A1
(en)
|
2013-05-10 |
2014-11-13 |
Biontech Ag |
Predicting immunogenicity of t cell epitopes
|
SG11201508273RA
(en)
|
2013-05-18 |
2015-12-30 |
Aduro Biotech Inc |
Compositions and methods for activating "stimulator of interferon gene"-dependent signalling
|
WO2014200912A2
(en)
*
|
2013-06-10 |
2014-12-18 |
Iogenetics, Llc |
Mathematical processes for determination of peptidase cleavage
|
EP3777882A1
(en)
|
2013-07-30 |
2021-02-17 |
BioNTech SE |
Tumor antigens for determining cancer therapy
|
AU2014298504B2
(en)
|
2013-07-30 |
2018-08-30 |
Biontech Ag |
Tumor antigens for determining cancer therapy
|
CN105682683A
(zh)
|
2013-08-02 |
2016-06-15 |
阿杜罗生物科技控股有限公司 |
结合cd27激动剂以及免疫检查点抑制以用于免疫刺激
|
TWI714869B
(zh)
|
2013-08-05 |
2021-01-01 |
德商伊瑪提克斯生物科技有限公司 |
新穎肽類,細胞及其用於治療多種腫瘤的用途,其製造方法及包含其等之醫藥組成物
|
EP2959021B1
(en)
|
2013-08-19 |
2018-08-08 |
BioNTech Diagnostics GmbH |
Methods and kits for the molecular subtyping of tumors
|
RU2690241C2
(ru)
|
2013-08-19 |
2019-05-31 |
Бионтех Диагностикс Гмбх |
Способы и наборы для молекулярного субтипирования опухолей
|
WO2015030585A2
(en)
|
2013-08-27 |
2015-03-05 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Methods for detecting post-translationally modified lysines in a polypeptide
|
WO2015032906A2
(en)
|
2013-09-05 |
2015-03-12 |
Bionovion Holding B.V. |
Cd70-binding peptides and method, process and use relating thereto
|
NL2011406C2
(en)
|
2013-09-06 |
2015-03-10 |
Bionovion Holding B V |
Method for obtaining april-binding peptides, process for producing the peptides, april-binding peptides obtainable with said method/process and use of the april-binding peptides.
|
WO2015043613A1
(en)
|
2013-09-26 |
2015-04-02 |
Biontech Ag |
Particles comprising a shell with rna
|
WO2015058780A1
(en)
|
2013-10-25 |
2015-04-30 |
Biontech Ag |
Method and kit for determining whether a subject shows an immune response
|
EP3060679B1
(en)
|
2013-10-25 |
2019-06-12 |
BioNTech Diagnostics GmbH |
Method and kit for determining whether a subject shows an immune response
|
KR102006527B1
(ko)
|
2013-11-01 |
2019-08-02 |
화이자 인코포레이티드 |
전립선-연관 항원의 발현을 위한 벡터
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
US11725237B2
(en)
|
2013-12-05 |
2023-08-15 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
NZ721908A
(en)
*
|
2013-12-20 |
2022-12-23 |
Massachusetts Gen Hospital |
Combination therapy with neoantigen vaccine
|
PE20161344A1
(es)
|
2014-01-02 |
2016-12-23 |
Memorial Sloan Kettering Cancer Center |
Determinantes de respuesta del cancer a la inmunoterapia
|
KR102514910B1
(ko)
*
|
2014-01-27 |
2023-03-29 |
몰레큘러 템플레이츠, 인코퍼레이션. |
폴리펩티드를 전달하는 mhc 클래스 i 항원결정기
|
EP3099706B1
(en)
|
2014-01-29 |
2018-10-31 |
BioNTech AG |
Peptide mimotopes of claudin 18.2 and uses thereof
|
JP6580579B2
(ja)
|
2014-01-29 |
2019-09-25 |
ユニバーシティー ヘルス ネットワーク |
T細胞受容体を発現する細胞を生産する方法および組成物
|
JP2017511796A
(ja)
|
2014-02-18 |
2017-04-27 |
アドバクシス, インコーポレイテッド |
多標的免疫療法を目的とするバイオマーカー
|
KR20160122829A
(ko)
|
2014-02-25 |
2016-10-24 |
어드박시스, 인크. |
Her2/neu 과발현 종양의 치료를 위한 조성물 및 방법
|
EP3113794A4
(en)
|
2014-03-05 |
2017-09-06 |
Advaxis, Inc. |
Methods and compositions for increasing a t-effector cell to regulatory t cell ratio
|
US20150278441A1
(en)
*
|
2014-03-25 |
2015-10-01 |
Nec Laboratories America, Inc. |
High-order semi-Restricted Boltzmann Machines and Deep Models for accurate peptide-MHC binding prediction
|
AU2015250111A1
(en)
|
2014-04-24 |
2016-12-08 |
Advaxis, Inc. |
Recombinant listeria vaccine strains and methods of producing the same
|
GB201408255D0
(en)
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
EP2944955A1
(en)
|
2014-05-13 |
2015-11-18 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Benchmark for LC-MS systems
|
WO2015172843A1
(en)
|
2014-05-16 |
2015-11-19 |
Biontech Diagnostics Gmbh |
Methods and kits for the diagnosis of cancer
|
GB201411037D0
(en)
|
2014-06-20 |
2014-08-06 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
|
US10000533B2
(en)
|
2014-06-20 |
2018-06-19 |
Immatics Biotechnologies Gmbh |
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
|
SG11201701149SA
(en)
|
2014-07-18 |
2017-04-27 |
Advaxis Inc |
Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer
|
WO2016011320A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Bivalent listeria-based delivery system of heterologous antigens
|
CA2955432A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Listeria-based immunogenic compositions for eliciting anti-tumor responses
|
US10564165B2
(en)
|
2014-09-10 |
2020-02-18 |
Genentech, Inc. |
Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic information
|
WO2016040900A1
(en)
|
2014-09-14 |
2016-03-17 |
Washington University |
Personalized cancer vaccines and methods therefor
|
KR102541849B1
(ko)
|
2014-09-15 |
2023-06-09 |
에이비비트로, 엘엘씨 |
고-처리량 뉴클레오티드 라이브러리 서열결정
|
CA3017170C
(en)
|
2014-09-17 |
2021-03-23 |
The Johns Hopkins University |
Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cells
|
JP2017532325A
(ja)
|
2014-10-03 |
2017-11-02 |
イエール ユニバーシティ |
抗癌療法のための自然免疫系の改変
|
WO2016062323A1
(en)
|
2014-10-20 |
2016-04-28 |
Biontech Ag |
Methods and compositions for diagnosis and treatment of cancer
|
CA2964948A1
(en)
|
2014-10-31 |
2016-05-06 |
The Trustees Of The University Of Pennsylvania |
Altering gene expression in modified t cells and uses thereof
|
DE102014116335A1
(de)
|
2014-11-10 |
2016-05-12 |
Thyssenkrupp Ag |
Verbundwerkstoff, Verbundwerkstoffprodukt, Verfahren zu deren Herstellung und Verwendungen dafür
|
MA40737A
(fr)
|
2014-11-21 |
2017-07-04 |
Memorial Sloan Kettering Cancer Center |
Déterminants de la réponse d'un cancer à une immunothérapie par blocage de pd-1
|
MA41218A
(fr)
|
2014-12-19 |
2017-10-24 |
Advaxis Inc |
Combinaison de vaccin à base de listeria comportant des anticorps anti-ox40 ou anti-gitr
|
EP3234130B1
(en)
|
2014-12-19 |
2020-11-25 |
The Broad Institute, Inc. |
Methods for profiling the t-cell- receptor repertoire
|
EP3234193B1
(en)
|
2014-12-19 |
2020-07-15 |
Massachusetts Institute of Technology |
Molecular biomarkers for cancer immunotherapy
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
CA3224830A1
(en)
|
2015-01-08 |
2016-07-14 |
Biontech Ag |
Agonistic tnf receptor binding agents
|
NL2014108B1
(en)
|
2015-01-09 |
2016-09-30 |
Aduro Biotech Holdings Europe B V |
Altered april binding antibodies.
|
WO2016126876A2
(en)
|
2015-02-03 |
2016-08-11 |
Advaxis, Inc. |
Listeria-based adjuvants
|
US20160220652A1
(en)
|
2015-02-03 |
2016-08-04 |
Advaxis, Inc. |
Methods of using recombinant listeria vaccine strains in disease immunotherapy
|
WO2016128316A1
(en)
|
2015-02-09 |
2016-08-18 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Means and methods for minimizing swept and dead volumes in chromatographic applications
|
WO2016128060A1
(en)
|
2015-02-12 |
2016-08-18 |
Biontech Ag |
Predicting t cell epitopes useful for vaccination
|
CN107889509B
(zh)
|
2015-02-17 |
2022-02-11 |
百欧恩泰诊断有限责任公司 |
用于膀胱癌分子亚型分型的方法和试剂盒
|
MA41644A
(fr)
|
2015-03-03 |
2018-01-09 |
Advaxis Inc |
Compositions à base de listeria comprenant un système d'expression de minigènes codant pour des peptides, et leurs procédés d'utilisation
|
US20160317654A1
(en)
|
2015-03-09 |
2016-11-03 |
Kings College London |
Combination therapy with rar alpha agonists for enhancing th1 response
|
WO2016145578A1
(en)
|
2015-03-13 |
2016-09-22 |
Syz Cell Therapy Co. |
Methods of cancer treatment using activated t cells
|
GB201504502D0
(en)
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
WO2016154412A2
(en)
|
2015-03-26 |
2016-09-29 |
The Trustees Of The University Of Pennsylvania |
Combination of a pd-1 antagonist and a listeria based vaccine for treating pancreatic cancer
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
GB201505585D0
(en)
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
WO2016155809A1
(en)
|
2015-03-31 |
2016-10-06 |
Biontech Rna Pharmaceuticals Gmbh |
Lipid particle formulations for delivery of rna and water-soluble therapeutically effective compounds to a target cell
|
US9808516B2
(en)
|
2015-04-13 |
2017-11-07 |
Aduro Biotech, Inc. |
Immunogenic fusion proteins for the treatment of cancer
|
CR20170507A
(es)
|
2015-04-13 |
2018-02-13 |
Aduro Biotech Inc |
Fusiones de variante iii del receptor de factor de crecimiento epidérmico-mesotelina y métodos para usar los mismos.
|
WO2016172624A1
(en)
|
2015-04-22 |
2016-10-27 |
Agenus Inc. |
Methods for treating cancer
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
IL298497A
(en)
|
2015-04-27 |
2023-01-01 |
Cancer Research Tech Ltd |
A method for treating cancer
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
US10259882B2
(en)
|
2015-05-07 |
2019-04-16 |
Agenus Inc. |
Anti-OX40 antibodies
|
WO2016180467A1
(en)
|
2015-05-11 |
2016-11-17 |
Biontech Cell & Gene Therapies Gmbh |
Enhancing the effect of car-engineered t cells by means of nucleic acid vaccination
|
SG10201912485PA
(en)
|
2015-05-13 |
2020-02-27 |
Agenus Inc |
Vaccines for treatment and prevention of cancer
|
WO2016183361A1
(en)
|
2015-05-13 |
2016-11-17 |
Advaxis, Inc. |
Immunogenic listeria-based compositions comprising truncated acta-antigen fusions and methods of use thereof
|
WO2016187508A2
(en)
|
2015-05-20 |
2016-11-24 |
The Broad Institute Inc. |
Shared neoantigens
|
US10293637B2
(en)
|
2015-05-21 |
2019-05-21 |
Burley Design Llc |
Bicycle quick release cam lever with biased closure
|
CA2987239A1
(en)
|
2015-05-26 |
2016-12-01 |
Advaxis, Inc. |
Personalized delivery vector-based immunotherapy and uses thereof
|
CA2986765A1
(en)
|
2015-05-29 |
2016-12-08 |
Agenus Inc. |
Anti-ctla-4 antibodies and methods of use thereof
|
GB201510771D0
(en)
|
2015-06-19 |
2015-08-05 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
|
US20170204361A1
(en)
|
2015-06-24 |
2017-07-20 |
Advaxis, Inc. |
Manufacturing device and process for personalized delivery vector-based immunotherapy
|
GB201511191D0
(en)
|
2015-06-25 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
T-cell epitopes for the immunotherapy of myeloma
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
GB201511792D0
(en)
|
2015-07-06 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers
|
EP3115369A1
(en)
|
2015-07-09 |
2017-01-11 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Peptide purification using mixed-phase solid phase extraction material
|
GB201512369D0
(en)
|
2015-07-15 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
|
WO2017017232A1
(en)
|
2015-07-29 |
2017-02-02 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Means and methods for a sample preparation, especially for mass spectrometry
|
WO2017024006A1
(en)
|
2015-08-03 |
2017-02-09 |
The Johns Hopkins University |
Personalized, allogeneic cell therapy of cancer
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
WO2017030956A1
(en)
|
2015-08-14 |
2017-02-23 |
Agenus Inc. |
Method of inducing a t-cell response to phosphopeptides using nucleic acids encoding phosphopeptide mimetics
|
GB201515321D0
(en)
|
2015-08-28 |
2015-10-14 |
Immatics Biotechnologies Gmbh |
Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
|
US10335471B2
(en)
|
2015-08-28 |
2019-07-02 |
Immatics Biotechnologies Gmbh |
Method for treating cancer with activated T cells
|
KR20220131277A
(ko)
|
2015-09-01 |
2022-09-27 |
아게누스 인코포레이티드 |
항-pd-1 항체 및 이를 이용하는 방법
|
KR20180083327A
(ko)
|
2015-10-12 |
2018-07-20 |
난토믹스, 엘엘씨 |
바이러스성 암 네오에피토프를 위한 조성물 및 방법
|
US10546650B2
(en)
*
|
2015-10-23 |
2020-01-28 |
Google Llc |
Neural network for processing aptamer data
|
WO2017106185A2
(en)
|
2015-12-14 |
2017-06-22 |
Bellicum Pharmaceuticals, Inc. |
Dual controls for therapeutic cell activation or elimination
|
US20170199961A1
(en)
|
2015-12-16 |
2017-07-13 |
Gritstone Oncology, Inc. |
Neoantigen Identification, Manufacture, and Use
|
US10497089B2
(en)
*
|
2016-01-29 |
2019-12-03 |
Fotonation Limited |
Convolutional neural network
|
WO2017184590A1
(en)
|
2016-04-18 |
2017-10-26 |
The Broad Institute Inc. |
Improved hla epitope prediction
|
CN110545810A
(zh)
|
2016-11-23 |
2019-12-06 |
磨石肿瘤生物技术公司 |
新抗原的病毒递送
|
KR20180063481A
(ko)
|
2016-12-02 |
2018-06-12 |
주식회사 원소프트다임 |
체지방을 측정하는 클라우드 기반 휴대용 장치를 이용하여 헬스케어 정보를 제공하는 방법 및 이를 이용하는 장치
|
CN110799196B
(zh)
*
|
2017-03-31 |
2024-02-13 |
行动基因(智财)有限公司 |
致免疫性的癌症特异抗原决定位的排名系统
|
US20210113673A1
(en)
|
2017-04-19 |
2021-04-22 |
Gritstone Oncology, Inc. |
Neoantigen Identification, Manufacture, and Use
|
WO2018227030A1
(en)
|
2017-06-09 |
2018-12-13 |
Gritstone Oncology, Inc. |
Neoantigen identification, manufacture, and use
|
CN111315390A
(zh)
|
2017-09-05 |
2020-06-19 |
磨石肿瘤生物技术公司 |
用于t细胞疗法的新抗原鉴别
|
AU2018348165A1
(en)
|
2017-10-10 |
2020-05-21 |
Gritstone Bio, Inc. |
Neoantigen identification using hotspots
|
EP3714275A4
(en)
|
2017-11-22 |
2021-10-27 |
Gritstone bio, Inc. |
REDUCTION OF JUNCTION EPITOPIC PRESENTATION FOR NEOANTIGENS
|
KR20200127001A
(ko)
|
2018-02-27 |
2020-11-09 |
그릿스톤 온콜로지, 인코포레이티드 |
범-대립유전자 모델을 갖는 신생항원 동정
|